EGFR and lung cancer: In contrast, Argentina and Uruguay have the lowest rates of EGFR mutations in LATAM, a finding related to a strong history of Italian and European immigration and perhaps the higher tobacco consumption rates in these countries.21 According to the GLOBOCAN database, lung cancers in women range from 20% of the total patients in Paraguay to as high as 50% of the patients in Peru and Bolivia, whereas the incidence of women with lung cancers with EGFR mutations in LATAM can range from 25% to 60% in Peru.18 In most LATAM countries, we see more EGFR mutations in women compared with men.